MATD3

ONconsolidated

HOSPITAL MATER DEI S.A.

CNPJ 16676520000159

Last close
R$ 6.85
2026-10-09
Over the window
+59.67%
2025-10-10 → 2026-10-09
High / Low
6.85 / 4.13
intraday · 249 sessions
Avg. volume
1.60m
21-session average
6.85close4.19
Monthly closes

—

Return 1 year
+49.24%
nominal from 2025-09 · real +5.42%, to 2026-09
Return 3 years
-21.26%
nominal from 2023-09 · real -49.36%, to 2026-09
Return 5 years
-62.77%
nominal from 2021-09 · real -78.76%, to 2026-09
Return 10 years
—
no history covering the window

Ratios

Q3 25 → Q2 26
Valuation
Price / Earnings
16.31
Price / Book
1.52
Book value per share: R$ 4.52
Market cap
2.28bn
Shares issued: 333,548,825
Earnings per share (12m)
R$ 0.42
Q3 25 → Q2 26
Price / Sales
0.99
Price / Assets
0.52
Price / Working capital
2.25
EV / EBITDA
5.86
EV / EBIT
7.53
Efficiency
Gross margin
30.3%
EBITDA margin
22.3%
EBITDA (12m): 516.00m
Operating margin
17.3%
Net margin
6.1%
Asset turnover
0.53
Revenue (12m)
2.32bn
Net income (12m): 142.21m
Returns
ROE
9.4%
ROA
3.3%
Debt and structure
Assets / Equity
2.91
Current ratio
2.87
Net debt
737.05m
Gross debt: 1.36bn
Debt / Equity
0.91
Equity / Assets
0.34
Distributions
Dividend yield (12m)
2.2%
twelve months to 2026-10-09, the last session
Distributions per share (12m)
R$ 0.1505
Payout (12m)
35.3%
Growth
Revenue CAGR (5y)
—
Earnings CAGR (5y)
—

Share capital from the FRE dated 2026-12-31. The FRE is annual — buybacks and issuances after that date are not reflected here.

computed — The CVM does not publish Q4 on its own — the annual filing carries the full year. This figure is the year minus the first nine months.

Distributions

TypeApproved onEx-date basisR$ / share
DIVIDENDO2025-12-032025-12-080.150522
DIVIDENDO2025-05-082025-05-130.074861
DIVIDENDO2024-04-302024-04-300.074861
DIVIDENDO2023-04-282023-04-280.064345
DIVIDENDO2022-04-292022-04-290.090022

Gross amounts, by record date, from B3's registry — the Type column separates dividends, interest on equity and capital returns, and the 12-month yield adds all of them. A capital return is a refund, not income. Interest on equity (JCP) carries 15% withholding tax for individuals — the net yield is lower. Payment dates are not in this registry; they live in the shareholder notice.

Ratios by year

YearRevenueNet incomeGross marginNet marginROEROATurnoverYear-end priceP/EDY
20252.18bn111.92m30.0%5.1%7.6%2.6%0.505.2615.944.3%
20242.23bn-323.90m30.1%-14.6%-21.9%-7.5%0.513.64—2.1%
20232.19bn141.25m32.5%6.5%8.1%2.7%0.428.3526.940.8%
20221.76bn122.69m35.4%7.0%7.2%2.5%0.367.2126.701.3%
20211.02bn146.85m39.5%14.3%8.7%3.6%0.2513.5028.12—

From each fiscal year's DFP, with the close of the fiscal year-end month alongside. Yearly P/E and DY use the fiscal year-end close against that year's EPS and payouts — both already per share. An empty cell carries its reason in the tooltip: a loss, EPS out of scale, lot-of-a-thousand quoting, a split in the way. Yearly P/B is left out: it would need that year's share count, and the registration filing stores the latest approval's count under the reference date.

The table is entirely consolidated — the side that closes the most recent 12 months. The fiscal years 2020 exist only on the standalone side and are left out: mixing both sides in one column would compare figures of different natures.

Quarterly results

PeriodRevenueOperatingNet incomeNet margin
Q2 26613.63m109.26m44.99m7.3%
Q1 26574.96m95.48m32.57m5.7%
Q4 25562.30m98.31m37.17m6.6%
Q3 25567.86m98.11m27.48m4.8%
Q2 25545.81m88.00m27.09m5.0%
Q1 25499.32m69.31m20.17m4.0%
Q4 24487.04m50.65m8.15m1.7%
Q3 24570.82m153.68m80.53m14.1%
Q2 24585.34m-652.32m-458.54m-78.3%
Q1 24582.80m112.15m45.96m7.9%
Q4 23541.22m86.50m28.49m5.3%
Q3 23568.23m108.76m35.23m6.2%

Balance sheet

PeriodTotal assetsEquityAssets / EquityCurrent ratio
Q2 264.38bn1.51bn2.912.87
Q1 264.33bn1.51bn2.872.91
Q4 254.31bn1.48bn2.923.04
Q3 254.40bn1.49bn2.952.92
Q2 254.34bn1.48bn2.933.09
Q1 254.38bn1.49bn2.952.95
Q4 244.34bn1.48bn2.943.16
Q3 244.41bn1.50bn2.943.53
Q2 244.93bn1.58bn3.122.49
Q1 245.26bn1.79bn2.952.34
Q4 235.17bn1.75bn2.952.59
Q3 235.17bn1.76bn2.932.68

A balance sheet is a snapshot, not a window: there is no “computed Q4” here — December's figure is what the annual filing published.

What the company filed

FilingPeriodFiled onDays after closeDocument
ITRT22026-06-302026-08-1243CVM ↗
ITRT12026-03-312026-05-0636CVM ↗
DFPanual2025-12-312026-03-2281CVM ↗
ITRT32025-09-302025-11-0940CVM ↗
ITRT22025-06-302025-08-1344CVM ↗
ITRT12025-03-312025-05-0838CVM ↗
DFPanual2024-12-312025-03-1978CVM ↗
ITRT32024-09-302024-11-0738CVM ↗
ITRT22024-06-302024-08-0839CVM ↗
ITRT12024-03-312024-05-0737CVM ↗
DFPanual2023-12-312024-03-2888CVM ↗
ITRT32023-09-302023-11-1344CVM ↗
ITRT22023-06-302023-08-1041CVM ↗
ITRT12023-03-312023-05-1545CVM ↗
DFPanual2022-12-312023-03-1675CVM ↗
ITRT32022-09-302022-11-0940CVM ↗

When the next one is due

Next period
2026-09-30
ITR
Estimated filing
2026-11-10
Median
41 days
17 filings measured
Range
36–45 days

This is measured habit, not company guidance: the CVM publishes no forward calendar as open data. The estimate applies this company's historical median to the next period.